SPT Labtech’s Acquisition of Apricot Designs Expands Liquid Handling Technologies Portfolio

Publication
Article
In the Lab eNewsletterPharmaceutical Technology's In the Lab eNewsletter 02-03-2021
Volume 16
Issue 2

Through the acquisition, SPT will have the ability to expand its portfolio of liquid handling technologies as part of its larger portfolio of automation solutions for drug discovery, structural biology, genomics, cryo-EM, sample management, and biobanking.

SPT Labtech, an automated instrumentation and consumables designer and developer, has acquired Apricot Designs, a US-based laboratory equipment supplier, in the latter half of January 2021.

Through the acquisition, SPT will have the ability to expand its portfolio of liquid handling technologies as part of its larger portfolio of automation solutions for drug discovery, structural biology, genomics, cryo-electron microscopy, sample management, and biobanking, SPT said in a Jan. 21, 2021 company press release. The agreement will also increase SPT’s global footprint through Apricot’s US and Asia locations.

"We are delighted to welcome Apricot Designs to the SPT Labtech group,” said Patrick Bennett, group CEO at SPT Labtech, in the press release. “The company's liquid handling technology products seamlessly complement our existing portfolio of high-performance positive displacement instruments. The addition reflects our continued commitment to accelerating scientific research by maximizing our customers' productivity. The powerful combination of technologies and application know-how will enable us to streamline end-to-end workflows and serve a wider range of research applications."

"We are delighted to join SPT Labtech, a company with an impressive reputation for creating innovative, automated solutions for life sciences,” added Felix H. Yiu, CEO of Apricot Designs, in the press release. “We are confident that customers will benefit from the partnership's combined product capabilities, industry-leading applications and technical support, and enhanced infrastructure."

Source: SPT Labtech

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content